A NOVEL THERAPEUTIC TARGET FOR MITOCHONDRIAL DYSFUNCTION

A Novel Therapeutic Target for Mitochondrial Dysfunction

Mitochondrial dysfunction is a major contributor to a wide range of complex diseases. This dysregulation in mitochondrial function can lead to cellular damage, ultimately resulting in various pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising approach for addressing this debilitating problem. EPT Fumarate operates by

read more